Nemes Rush Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.6M | Buy |
14,898
+553
| +4% | +$431K | 1.26% | 26 |
|
|
2025
Q1 | $11.8M | Buy |
14,345
+204
| +1% | +$168K | 1.5% | 22 |
|
|
2024
Q4 | $10.9M | Buy |
14,141
+835
| +6% | +$645K | 1.35% | 26 |
|
|
2024
Q3 | $10.4M | Sell |
13,306
-392
| -3% | -$305K | 1.5% | 23 |
|
|
2024
Q2 | $12.4M | Buy |
13,698
+326
| +2% | +$295K | 1.7% | 18 |
|
|
2024
Q1 | $10.4M | Buy |
13,372
+10,433
| +355% | +$8.12M | 1.49% | 23 |
|
|
2023
Q4 | $1.71M | Sell |
2,939
-132
| -4% | -$77K | 0.28% | 67 |
|
|
2023
Q3 | $1.65M | Sell |
3,071
-36
| -1% | -$19.3K | 0.3% | 68 |
|
|
2023
Q2 | $1.46M | Buy |
+3,107
| New | +$1.46M | 0.26% | 74 |
|